Abdulraheem Yacoub

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 15

Top Topics

Clostridium Difficile

Prognostic Factors

Chronic Myeloid Leukemia

Top Venues

JCO precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Abdulraheem Yacoub, Uma Borate, Raajit K Rampal, Haris Ali, Eunice S Wang, Aaron T Gerds, Gabriela Hobbs, Marina Kremyanskaya, Elliott Winton, Casey O'Connell, Swati Goel, Stephen T Oh, Gary Schiller, James McCloskey, Jeanne M Palmer, Houston Holmes, Steven Hager, Albert Assad, Susan Erickson-Viitanen, Feng Zhou, Naval G Daver
Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results. Blood advances 8 (6) (2024)
Abdulraheem Yacoub, Uma Borate, Raajit K Rampal, Haris Ali, Eunice S Wang, Aaron T Gerds, Gabriela Hobbs, Marina Kremyanskaya, Elliott Winton, Casey O'Connell, Swati Goel, Stephen T Oh, Gary Schiller, James McCloskey, Jeanne M Palmer, Houston Holmes, Steven Hager, Albert Assad, Susan Erickson-Viitanen, Feng Zhou, Naval G Daver
Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results. Blood advances 8 (6) (2024)
Abdulraheem Yacoub, Uma Borate, Raajit K Rampal, Haris Ali, Eunice S Wang, Aaron T Gerds, Gabriela Soriano Hobbs, Marina Kremyanskaya, Elliott F Winton, Casey O'Connell, Swati Goel, Stephen T Oh, Gary J Schiller, James McCloskey, Jeanne M Palmer, Houston Holmes, Steven Hager, Albert Assad, Susan Erickson-Viitanen, Feng Zhou, Naval G Daver
Phase 2 study of add-on parsaclisib in myelofibrosis patients with suboptimal response to ruxolitinib: Final results. Blood advances (2024)
Abdulraheem Yacoub, Uma Borate, Raajit K Rampal, Haris Ali, Eunice S Wang, Aaron T Gerds, Gabriela Hobbs, Marina Kremyanskaya, Elliott Winton, Casey O'Connell, Swati Goel, Stephen T Oh, Gary Schiller, James McCloskey, Jeanne M Palmer, Houston Holmes, Steven Hager, Albert Assad, Susan Erickson-Viitanen, Feng Zhou, Naval G Daver
Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results. Blood advances 8 (6) (2024)
Abdulraheem Yacoub, Ruben A Mesa, Stephen T Oh
Long-Term Hematologic Improvement in a Patient With Cytopenic Myelofibrosis Treated With Pacritinib. JCO precision oncology 7 (2023)
John O Mascarenhas, Anna Rita Migliaccio, Heidi E Kosiorek, Rupali Bhave, Jeanne M Palmer, Andrew T Kuykendall, Ruben A Mesa, Raajit K Rampal, Aaron T Gerds, Abdulraheem Yacoub, Kristen Pettit, Moshe Talpaz, Rami S Komrokji, Marina Kremyanskaya, Agapito Gonzalez, Frank Fabris, Kathryn Johnson, Mikaela Dougherty, Erin M McGovern, Juan Esteban Arango Ossa, Dylan Domenico, Noushin Farnoud, Rona Singer Weinberg, Amy Kong, Vesna Najfeld, Alessandro Maria Maria Vannucchi, Francesca Arciprete, Maria Zingariello, Mario Falchi, Mohamed E Salama, Carolyn Mead-Harvey, Amylou C Dueck, Lilian Varricchio, Ronald Hoffman
A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Abdulraheem Yacoub, Ruben A Mesa, Stephen T Oh
Long-Term Hematologic Improvement in a Patient With Cytopenic Myelofibrosis Treated With Pacritinib. JCO precision oncology 7 (2023)
Abdulraheem Yacoub, Ruben A Mesa, Stephen T Oh
Long-Term Hematologic Improvement in a Patient With Cytopenic Myelofibrosis Treated With Pacritinib. JCO precision oncology 7 (2023)
Moazzam Shahzad, Sibgha Gull Chaudhary, Ezza Tariq, Ali Hassan Mushtaq, Iqra Anwar, Nausheen Ahmed, Rajat Bansal, Forat Lutfi, Ramesh Balusu, Haitham Abdelhakim, Abdulraheem Yacoub, Peiman Hematti, Anurag K Singh, Joseph P McGuirk, Muhammad Umair Mushtaq
Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic review. Leukemia & lymphoma (2022)
Jesus D Gonzalez-Lugo, Suman Kambhampati, Abdulraheem Yacoub, William B Donnellan, Jesus G Berdeja, Prafulla Bhagat, Karen Fehn, Cassady Remy, Sakshi Jasra, Mohammed Kazemi, Kith Pradhan, Mimi Y Kim, Ioannis Mantzaris, R Alejandro Sica, Nishi Shah, Mendel Goldfinger, Noah Kornblum, Kira Gritsman, Ira Braunschweig, Ulrich Steidl, Britta Will, Aditi Shastri, Amit K Verma
Lenalidomide and Eltrombopag for Treatment of Low or Intermediate Risk Myelodysplastic Syndrome: Result of a Phase 2 Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
John O Mascarenhas, Heidi E Kosiorek, Josef T Prchal, Alessandro Rambaldi, Dmitriy Berenzon, Abdulraheem Yacoub, Claire N Harrison, Mary Frances Frances McMullin, Alessandro Maria Maria Vannucchi, Joanne Ewing, Casey L O'Connell, Jean-Jacques Kiladjian, Adam J Mead, Elliott F Winton, David S Leibowitz, Valerio De Stefano, Murat O Arcasoy, Craig M Kessler, Rosalind Catchatourian, Damiano Rondelli, Richard T Silver, Andrea Bacigalupo, Arnon Nagler, Marina Kremyanskaya, Max Fine Levine, Juan Esteban Arango Ossa, Erin M McGovern, Lonette Sandy, Mohamad E Salama, Vesna Najfeld, Joseph Tripodi, Noushin Farnoud, Alexander V Penson, Rona Singer Weinberg, Leah Price, Judith D Goldberg, Tiziano Barbui, Roberto Marchioli, Gianni Tognoni, Raajit K Rampal, Ruben A Mesa, Amylou C Dueck, Ronald Hoffman
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia. Blood 139 (19) (2022)
Aaron T Gerds, Bartalucci Niccolò, Albert Assad, Abdulraheem Yacoub
Targeting the PI3K pathway in myeloproliferative neoplasms. Expert review of anticancer therapy 22 (8) (2022)
John O Mascarenhas, Francesco Passamonti, Kate Burbury, Tarec Christoffer El-Galaly, Aaron T Gerds, Vikas K Gupta, Brian Higgins, Kathrin Wonde, Candice Jamois, Bruno Kovic, Ling-Yuh Huw, Sudhakar Katakam, Margherita Maffioli, Ruben A Mesa, Jeanne Palmer, Marta Bellini, David Morrall Ross, Alessandro Maria Maria Vannucchi, Abdulraheem Yacoub
The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study. Blood advances 6 (4) (2022)
Talal W Khan, Abdulraheem Yacoub
Pitfalls in Interventional Pain Medicine: Hyponatremia after DDAVP for a Patient with Von Willebrand Disease Undergoing an Epidural Steroid Injection. Case reports in anesthesiology 2017 (2017)
Laura E Brown, Da Zhang, Diane L Persons, Abdulraheem Yacoub, Shivani Ponnala, Wei Cui
A 26-Year-Old Female with Systemic Mastocytosis with Associated Myeloid Neoplasm with Eosinophilia and Abnormalities of PDGFRB, t(4;5)(q21;q33). Case reports in hematology 2016 (2016)